Hepion Pharmaceuticals Quote - HEPA

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.1745

Bid

0.1732

Ask

0.175

Volume

7,812,405

0.171 Day's Range 0.1858

0.121 52 Week Range 3.4899

Market Cap

1.214M

Previous Close

0.1866

Open

0.1849

Last Trade

1500

0.1745

(formt)

Last Trade Time

Financial Volume

US$ 1,382,625

VWAP

0.176978

Average Volume (3m)

8,296,085

Shares Outstanding

6,958,371

Dividend Yield

PE Ratio

-0.03

Earnings Per Share (EPS)

-7.03

Revenue

Net Profit

-48.93M

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.hepion.com

Headquarters

Wilmington, Delaware, USA

Founded

Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0.19. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0.121 to US$ 3.4899.

Hepion Pharmaceuticals currently has 6,958,371 shares outstanding. The market capitalization of Hepion Pharmaceuticals is US$1.30 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.03.

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 8-K - Current report

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0405	-18.8372093023	0.215	0.28	0.1559	83258418	0.2121061	CS
4	-0.3255	-65.1	0.5	0.7345	0.121	26764260	0.20750102	CS
12	-0.466	-72.7556596409	0.6405	0.74	0.121	8296085	0.20854831	CS
26	-0.6255	-78.1875	0.8	0.89	0.121	3645921	0.21194454	CS
52	-1.6455	-90.4120879121	1.82	3.4899	0.121	1895802	0.2459591	CS
156	-18.6055	-99.0708200213	18.78	26.6	0.121	804756	3.41296899	CS
260	-107.2255	-99.8375232775	107.4	123.6	0.121	1252781	28.36679842	CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?

The current share price of Hepion Pharmaceuticals is US$ 0.1745

How many Hepion Pharmaceuticals shares are in issue?

Hepion Pharmaceuticals has 6,958,371 shares in issue

What is the market cap of Hepion Pharmaceuticals?

The market capitalisation of Hepion Pharmaceuticals is USD 1.3M

What is the 1 year trading range for Hepion Pharmaceuticals share price?

Hepion Pharmaceuticals has traded in the range of US$ 0.121 to US$ 3.4899 during the past year

What is the PE ratio of Hepion Pharmaceuticals?

The price to earnings ratio of Hepion Pharmaceuticals is -0.03

What is the reporting currency for Hepion Pharmaceuticals?

Hepion Pharmaceuticals reports financial results in USD

What is the latest annual profit for Hepion Pharmaceuticals?

The latest annual profit of Hepion Pharmaceuticals is USD -48.93M

What is the registered address of Hepion Pharmaceuticals?

The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Hepion Pharmaceuticals website address?

The website address for Hepion Pharmaceuticals is www.hepion.com

Which industry sector does Hepion Pharmaceuticals operate in?

Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	731.1M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.87M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.57M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	731.1M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.5M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	341.8M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	237.15M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.44M